{
    "title": "114_hr4586",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as ``Lali's Law''.\n\nSEC. 2. OPIOID OVERDOSE REVERSAL MEDICATION ACCESS AND EDUCATION GRANT \n              PROGRAMS.\n\n    (a) Technical Clarification.--Effective as if included in the \nenactment of the Children's Health Act of 2000 (Public Law 106-310), \nsection 3405(a) of such Act (114 Stat. 1221) is amended by striking \n``Part E of title III'' and inserting ``Part E of title III of the \nPublic Health Service Act''.\n    (b) Amendment.--Title III of the Public Health Service Act is \namended by inserting after part D of such title (42 U.S.C. 254b et \nseq.) the following new part E:\n\n                     ``PART E--OPIOID USE DISORDER\n\n``SEC. 341. OPIOID OVERDOSE REVERSAL MEDICATION ACCESS AND EDUCATION \n              GRANT PROGRAMS.\n\n    ``(a) Grants to States.--The Secretary may make grants to States \nfor--\n            ``(1) developing standing orders for pharmacies regarding \n        opioid overdose reversal medication;\n            ``(2) encouraging pharmacies to dispense opioid overdose \n        reversal medication pursuant to a standing order;\n            ``(3) implementing best practices for persons authorized to \n        prescribe medication regarding--\n                    ``(A) prescribing opioids for the treatment of \n                chronic pain;\n                    ``(B) co-prescribing opioid overdose reversal \n                medication with opioids; and\n                    ``(C) discussing the purpose and administration of \n                opioid overdose reversal medication with patients;\n            ``(4) developing or adapting training materials and methods \n        for persons authorized to prescribe or dispense medication to \n        use in educating the public regarding--\n                    ``(A) when and how to administer opioid overdose \n                reversal medication; and\n                    ``(B) steps to be taken after administering opioid \n                overdose reversal medication; and\n            ``(5) educating the public regarding--\n                    ``(A) the public health benefits of opioid overdose \n                reversal medication; and\n                    ``(B) the availability of opioid overdose reversal \n                medication without a person-specific prescription.\n    ``(b) Certain Requirement.--A grant may be made under this section \nonly if the State involved has authorized standing orders regarding \nopioid overdose reversal medication.\n    ``(c) Preference in Making Grants.--In making grants under this \nsection, the Secretary shall give preference to States that--\n            ``(1) have not issued standing orders regarding opioid \n        overdose reversal medication;\n            ``(2) authorize standing orders that permit community-based \n        organizations, substance abuse programs, or other nonprofit \n        entities to acquire, dispense, or administer opioid overdose \n        reversal medication;\n            ``(3) authorize standing orders that permit police, fire, \n        or emergency medical services agencies to acquire and \n        administer opioid overdose reversal medication;\n            ``(4) have a higher per capita rate of opioid overdoses \n        than other applicant States; or\n            ``(5) meet any other criteria deemed appropriate by the \n        Secretary.\n    ``(d) Grant Terms.--\n            ``(1) Number.--A State may not receive more than one grant \n        under this section.\n            ``(2) Period.--A grant under this section shall be for a \n        period of 3 years.\n            ``(3) Amount.--A grant under this section may not exceed \n        $500,000.\n            ``(4) Limitation.--A State may use not more than 20 percent \n        of a grant under this section for educating the public pursuant \n        to subsection (a)(5).\n    ``(e) Applications.--To be eligible to receive a grant under this \nsection, a State shall submit an application to the Secretary in such \nform and manner and containing such information as the Secretary may \nrequire, including detailed proposed expenditures of grant funds.\n    ``(f) Reporting.--Not later than 3 months after the Secretary \ndisburses the first grant payment to any State under this section and \nevery 6 months thereafter for 3 years, such State shall submit a report \nto the Secretary that includes the following:\n            ``(1) The name and ZIP Code of each pharmacy in the State \n        that dispenses opioid overdose reversal medication under a \n        standing order.\n            ``(2) The total number of opioid overdose reversal \n        medication doses dispensed by each such pharmacy, specifying \n        how many were dispensed with or without a person-specific \n        prescription.\n            ``(3) The number of pharmacists in the State who have \n        participated in training pursuant to subsection (a)(4).\n    ``(g) Definitions.--In this section:\n            ``(1) Opioid overdose reversal medication.--The term \n        `opioid overdose reversal medication' means any drug, including \n        naloxone, that--\n                    ``(A) blocks opioids from attaching to, but does \n                not itself activate, opioid receptors; or\n                    ``(B) inhibits the effects of opioids on opioid \n                receptors.\n            ``(2) Standing order.--The term `standing order' means a \n        document prepared by a person authorized to prescribe \n        medication that permits another person to acquire, dispense, or \n        administer medication without a person-specific prescription.\n    ``(h) Authorization of Appropriations.--\n            ``(1) In general.--To carry out this section, there is \n        authorized to be appropriated $5,000,000 for the period of \n        fiscal years 2017 through 2019.\n            ``(2) Administrative costs.--Not more than 3 percent of the \n        amounts made available to carry out this section may be used by \n        the Secretary for administrative expenses of carrying out this \n        section.''.\n\nSEC. 3. CUT-GO COMPLIANCE.\n\n    Subsection (f) of section 319D of the Public Health Service Act (42 \nU.S.C. 247d-4) is amended by inserting before the period at the end the \nfollowing: ``(except such dollar amount shall be reduced by $5,000,000 \nfor fiscal year 2017)''.\n\n            Passed the House of Representatives May 12, 2016.\n\n            Attest:\n\n                                                 KAREN L. HAAS,\n\n                                                                 Clerk."
}